Skip to main content
Caplight Logo









Celliaz Co., Ltd.

Celliaz Co., Ltd.

Private
DaejeonHealthcare & Life Scienceshttps://celliaz.com/

Last Round

Seed

Sep 1, 2022

Company Overview

Celliaz Co., Ltd. is a biotechnology company that develops homeoprotein-based retinal regeneration therapies for degenerative retinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicineretinal regenerationbiotechgene therapyantibody therapyPROX1 modulationwet age-related macular degenerationwet-AMDretinitis pigmentosaophthalmologyAAV-based therapydrug discoverybiopharmatherapeutic pipelinepreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Celliaz Co., Ltd. Comparables

Compare Celliaz Co., Ltd. with similar companies based on industry and business-model similarity.

Celliaz Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Olive Bio Therapeutics
86%
Ray Therapeutics
77%
Atsena Therapeutics
77%

Celliaz Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 1, 2022

Celliaz Co., Ltd. Investors

Notable investors and investment history

Celliaz Co., Ltd. investors
InvestorRounds
GenaxisSeed
FuturePlaySeed
IBK ChanggongSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2022

    Seed round raised with participation from Genaxis, FuturePlay, IBK Changgong, and Seoul Biohub.

Celliaz Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Celliaz Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Celliaz Co., Ltd.'s valuation, stock price, and market status.

Is Celliaz Co., Ltd. a public or private company?

Celliaz Co., Ltd. is a private company.

What is the current stock price of Celliaz Co., Ltd.?

Celliaz Co., Ltd. is a private company with no public stock price. Caplight tracks Celliaz Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Celliaz Co., Ltd. worth (valuation)?

Valuation information for Celliaz Co., Ltd. is not publicly available.

Can I buy Celliaz Co., Ltd. stock?

Celliaz Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Celliaz Co., Ltd.'s last funding round?

Celliaz Co., Ltd.'s most recent funding round was Seed on September 1, 2022.

Who are the main investors in Celliaz Co., Ltd.?

Key investors in Celliaz Co., Ltd. include Genaxis, FuturePlay, IBK Changgong.

Will Celliaz Co., Ltd. IPO soon?

No public IPO plans have been announced for Celliaz Co., Ltd..

How can I track Celliaz Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Celliaz Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDaejeon
Year Founded2022
Last FundingSep 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?